The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 26, 2021
Filed:
Dec. 16, 2016
Applicant:
Midatech Pharma (Wales) Limited, Cardiff South Glamorgan, GB;
Inventors:
Paul Seaman, Cardiff, GB;
Katharine Bamsey, Cardiff, GB;
Nigel Thomas, Cardiff, GB;
Dewi Paice, Cardiff, GB;
Assignee:
MIDATECH PHARMA (WALES) LIMITED, Cardiff South Glamorgan, GB;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/16 (2006.01); A61K 9/00 (2006.01); A61K 47/26 (2006.01); A61K 47/38 (2006.01); A61K 31/00 (2006.01); A61K 38/13 (2006.01); A61K 47/10 (2017.01); A61K 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1647 (2013.01); A61K 9/0019 (2013.01); A61K 9/0051 (2013.01); A61K 9/1694 (2013.01); A61K 31/00 (2013.01); A61K 38/13 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/38 (2013.01); A61K 9/10 (2013.01);
Abstract
A controlled release pharmaceutical formulation is provided, comprising cyclosporine-loaded microparticles of a bioresorbable polymer comprising poly(D,L-lactide), wherein the mean diameter of the microparticles is in the range 20 μm to 40 μm. Also provided are medical uses of the pharmaceutical formulation, in particular in the treatment of uveitis, a process for production of the pharmaceutical formulation and injectable dosage forms, including those formulated for intravitreal injection.